https://www.idblanter.com/search/label/Template
https://www.idblanter.com
BLANTERORBITv101

Tocilizumab Label / Objectives assess the efficacy and safety of tocilizumab in patients with systemic sclerosis (ssc) in a phase ii study.

Friday, January 8, 2021